Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 3/20 | 0.38 |
| ▸ | FUCA1 | P04066 | 2/20 | 0.37 |
| ▸ | EED | O75530 | 2/20 | 0.36 |
| ▸ | ACHE | P22303 | 2/20 | 0.36 |
| ▸ | DRD2 | P14416 | 1/20 | 0.35 |
| ▸ | DRD3 | P35462 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5793687 | 0.86 | BCHE (0.40) | BCHEFUCA1ACHE | |
| SCHEMBL17220126 | 0.77 | BCHE (0.44) | BCHEFUCA1DRD2DRD3 | |
| SCHEMBL17220125 | 0.77 | BCHE (0.44) | BCHEFUCA1DRD2DRD3 | |
| SCHEMBL5793809 | 0.73 | TSHR (0.39) | FUCA1DRD2DRD3 | |
| SCHEMBL8176845 | 0.73 | FUCA1 (0.55) | FUCA1EEDACHE | |
| SCHEMBL25933662 | 0.71 | SIGMAR1 (0.47) | FUCA1ACHEDRD2DRD3 | |
| SCHEMBL3917960 | 0.70 | FUCA1 (0.43) | BCHEFUCA1ACHEDRD2 | |
| SCHEMBL19024339 | 0.70 | FUCA1 (0.43) | BCHEFUCA1ACHEDRD2 | |
| SCHEMBL3917962 | 0.70 | FUCA1 (0.43) | BCHEFUCA1ACHEDRD2 | |
| SCHEMBL4889413 | 0.70 | FUCA1 (0.43) | BCHEFUCA1ACHEDRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2006024955-A1 | AZABICYCLIC AMINE HISTAMINE-3 RECEPTOR ANTAGONISTS | PFIZER PRODUCTS INC. (US) | 2006-03-09 | — | — | WO | claimed |
| US-20060047114-A1 | Azabicyclic amine histamine-3 receptor antagonists | PFIZER INC | 2006-03-02 | — | — | US | claimed |
| WO-2006024955-A1 | AZABICYCLIC AMINE HISTAMINE-3 RECEPTOR ANTAGONISTS | PFIZER PRODUCTS INC. (US) | 2006-03-09 | — | — | WO | disclosed |
| US-20060047114-A1 | Azabicyclic amine histamine-3 receptor antagonists | PFIZER INC | 2006-03-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060047114-A1 | Azabicyclic amine histamine-3 receptor antagonists | HRH3, HRH4, HRH2 | BCHE 202/4885FUCA1 878/4885EED 476/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.